April 9
- April 11
The Cell & Gene Meeting on the Med is a premier European conference focusing on advanced therapy medicinal products (ATMPs). ATMPs are a revolutionary class of treatments that involve modifying a patient’s cells to fight disease. This conference unites researchers, developers, manufacturers, and other stakeholders from around the world who…
May 7
- May 11
The American Society of Gene & Cell Therapy (ASGCT) annual meeting is the premier gathering for scientists, physicians, industry leaders, and patient advocates working at the forefront of gene and cell therapy. This year’s meeting, taking place in Baltimore, MD from May 7th to 11th, 2024, promises to be an…
March 21
- March 21
The Boston Society Gene & Cell Therapy Conference, renowned for its focus on translating groundbreaking scientific ideas into practical industrial applications, returns for another enriching gathering. This year’s event promises to be an invaluable platform for researchers, engineers, and industry leaders to connect, share knowledge, and shape the future of…
Webinars
Produced by Bioanalysis Zone Recorded on December 11, 2023 Webinar available here. Webinar Description: In this webinar, Dominic Warrino discusses the bioanalytical considerations of immunogenicity of cell and gene therapies. Bioanalysis method development and method validation of immunogenicity assays for support of cell and…
Blogs
Recently, Matthew Pennington, PhD (one of KCAS’s Senior Scientists) was the senior author on a publication entitled “A Validated Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno Associated Viral Vectors in Bio Shedding Studies of Tears”. Below, Matt explains the significance in what they accomplished…
Blogs
In the rapidly evolving realm of flow cytometry, conventional flow cytometry is gradually being displaced by its advanced counterpart, spectral flow cytometry. These technologies, each with its unique strengths and applications, have revolutionized the way we analyze cells and particles. Let’s dive…
Blogs
As with the lineup of equine subjects above, cell populations can take similar forms and act the same in a lot of ways – but to the trained eye, there are clear…
Blogs
Being that it is a relatively “niche” segment of the industry, there are several key areas that need to be considered in the field of molecular services related to cell and gene therapies. First and foremost, it is important to recognize that regulatory guidelines within this field are…
Blogs
In 2022 we had 42 FDA Drug Approvals and 3 were Gene Therapies using a viral vector. 2 of the approvals in 2022 were AAV based. The third is manufactured by adding functional copies of the transgene to the patient’s own Hematopoietic Stem Cells (HSCs)…
Blogs
Cell and Gene Therapies (CGTs) has an estimated market size value in 2022 of USD 8.22 billion and a revenue forecast in 2030 of USD 24.5 billion. This is a CAGR (compound annual growth rate) of 14.6% from 2022 to 2030. Needless to say, the…
Blogs
With the extensive advances in technologies like CRISPR and CAR-T, cell and gene therapy has grown to become a viable way for treating Cancer as well as other diseases. Our team has over 100+ years of collective expertise in molecular services using qPCR and ddPCR for support of…
News
Dawn Dufield, PhD, Senior Director of Biopharmaceutical LC-MS/MS Services at KCAS, has been invited to lead a workshop discussion session on Lipidomics at an upcoming Gordon Research Conference from August 7-12 in Newry, ME. The event will be a week long conference highlighting recent developments in standardization, omics integration,…